Eton Pharmaceuticals (ETON) Share-based Compensation (2018 - 2026)
Eton Pharmaceuticals (ETON) posted Share-based Compensation of -$4.1 million for Q4 2025, down 170.01% sequentially from $5.8 million in Q3 2025, and down 87.38% YoY from -$32.1 million in Q4 2024.
Eton Pharmaceuticals (ETON) Share-based Compensation (2018 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Share-based Compensation for 8 years, with the latest figure at -$4.1 million in Q4 2025.
- Quarterly Share-based Compensation fell 87.38% year-over-year to -$4.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.4 million (down 617.64% YoY) and the FY2025 annual result came in at $5.0 million, down 7.33% from the prior year.
- Share-based Compensation declined to -$4.1 million in Q4 2025 per ETON's latest filing, from $5.8 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $8.5 million in Q2 2025 and troughed at -$4.1 million in Q4 2025.
- A 5-year average of $2.0 million and a median of $917500.0 in 2022 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2024 and 2025: Share-based Compensation tumbled 216300.0% in 2024, then soared 819.12% in 2025.
- Over 5 years, Share-based Compensation stood at $863000.0 in 2021, then climbed by 2.67% to $886000.0 in 2022, then slumped by 100.11% to -$1000.0 in 2023, then sank by 216300.0% to -$2.2 million in 2024, then sank by 87.38% to -$4.1 million in 2025.
- According to Business Quant data, Share-based Compensation over the past three periods registered -$4.1 million, $5.8 million, and $8.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | 7.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.98 Mn |
| Jun 30, 2026 | 7.98 Mn |
| Dec 31, 2025 | -4.06 Mn |
| Dec 31, 2025 | -4.06 Mn |
| Sep 30, 2025 | 5.79 Mn |
| Sep 30, 2025 | 5.79 Mn |
| Jun 30, 2025 | 8.51 Mn |
| Jun 30, 2025 | 8.51 Mn |
| Mar 31, 2025 | 7.55 Mn |
| Mar 31, 2025 | 7.55 Mn |
| Dec 31, 2024 | -2.16 Mn |
| Dec 31, 2024 | -2.16 Mn |
| Sep 30, 2024 | 5.27 Mn |
| Sep 30, 2024 | 5.27 Mn |
| Jun 30, 2024 | 6.41 Mn |
| Jun 30, 2024 | 6.41 Mn |
| Mar 31, 2024 | 821,000.00 |
| Mar 31, 2024 | 821,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Dec 31, 2023 | -1,000.00 |